DSM Nutritional Products buys CRINA feed additive business from Intervet International

21 April 2006

Intervet herewith publishes a press release by DSM.

Kaiseraugst (CH), 21st April 2006 

Intervet International and DSM Nutritional Products signed an agreement on sale and purchase of the CRINA business. In 2005, CRINA, located in Gland, Switzerland had annual sales of about EUR 6 million. CRINA is the pioneering company in plant extracts used as feed additives. The company employs 19 people. CRINA is specialized in digestibility modulators based on blends of essential oils. With the acquisition of CRINA DSM Nutritional Products will further strengthen its position in animal nutrition and health ingredients. Both parties have agreed not to disclose financial details from this deal. 

Plant extracts is one of the ingredient classes with high growth potential. It is increasingly used in poultry, swine and cattle feeds to stabilize the intestinal micro-flora, thus promoting animal health and stimulating its performance. 

“We are very pleased about this acquisition, as it further enriches our product range for the nutrition of animals. The CRINA products and brands are an attractive platform for launching some of the products we have in the pipeline” commented Krijn Rietveld, Senior Vice President New Business Development, DSM Nutritional Products. 

Ruurd Stolp, President of Intervet, explains: “With CRINA, Intervet divests the last part of its global feed additives business in its overall strategy to focus on the core business of vaccines and pharmaceuticals to keep animals healthy.” 

Intervet International 
Intervet, a business unit of Akzo Nobel, based in Boxmeer, the Netherlands, with sales of EUR 1,094 million in 2005, is dedicated to research and development, production and marketing of innovative animal health products. Intervet's product range, for use in livestock, companion animals, poultry and fish, includes vaccines, antiparasitics, anti-infectives, endocrine products and other pharmaceutical specialties. Intervet operates globally with its own marketing organizations. The company currently employs around 5,000 people. For further company information please visit www.intervet.com.

DSM Nutritional Products 
DSM Nutritional Products is the world's leading supplier of vitamins, carotenoids and other fine chemicals to the feed, food, pharmaceutical and personal care industries. The company has sales of about EUR 2 billion and a long tradition as a pioneer in the discovery of new products, new formulations and attractive applications for all industry segments. For further company information please visit www.dsmnutritionalproducts.com. 

DSM 
DSM is active worldwide in nutritional and pharma ingredients, performance materials and industrial chemicals. The company creates innovative products and services that help improve the quality of life. DSM’s products are used in a wide range of end markets and applications such as human and animal nutrition and health, cosmetics, pharmaceuticals, automotive and transport, coatings, housing and electrics & electronics (E&E). DSM’s strategy, named Vision 2010 – Building on Strengths, focuses on accelerating profitable and innovative growth of the company’s specialties portfolio. Market-driven growth, innovation and increased presence in emerging economies are key drivers of this strategy. The group has annual sales of over EUR 8 billion and employs some 22,000 people worldwide. DSM ranks among the global leaders in many of its fields. The company is headquartered in the Netherlands, with locations in Europe, Asia, Africa and the Americas. More information about DSM can be found at www.dsm.com. 

For more information: 

DSM Nutritional Products 
Thomas Breisach 
Tel. +41 (61) 6888514 
Fax +41 (61) 6873716 
e-mail: thomas.breisach@dsm.com 

Forward-looking statements 
This press release contains forward-looking statements. These statements are based on current expectations, estimates and projections of DSM management and information currently available to the company. The statements involve certain risks and uncertainties that are difficult to predict and therefore DSM does not guarantee that its expectations will be realized. Furthermore, DSM has no obligation to update the statements contained in this press release.